Suppr超能文献

综述:精神疾病中的甲状腺功能

Review: thyroid function in psychiatric illness.

作者信息

Hein M D, Jackson I M

机构信息

Division of Endocrinology, Brown University, Rhode Island Hospital, Providence 02903.

出版信息

Gen Hosp Psychiatry. 1990 Jul;12(4):232-44. doi: 10.1016/0163-8343(90)90060-p.

Abstract

The development of highly sensitive immunometric assays for thyroid-stimulating hormone (TSH) has provided increased understanding of thyroid hormone regulation but, paradoxically, has contributed to a kaleidoscopic complexity of thyroid function test variability in hospitalized patients with nonthyroidal illness (NTI). In primary hypothyroidism, an elevated TSH is the most sensitive chemical index available, although early cases may show a hyperresponse of TSH to thyrotropin-releasing hormone (TRH) stimulation when the TSH is still within the normal range. The ability of the new TSH assays to discriminate between normal and low levels now allows the diagnosis of thyrotoxicosis to be confirmed by a suppressed TSH in the presence of elevated serum thyroxine (T4) and/or triiodothyronine (T3). The TRH stimulation test is virtually obsolete for the diagnosis of thyrotoxicosis but remains of much interest in the investigation of psychiatric syndromes. Approximately 25% of patients with depression have a blunted TSH response (a rise of less than 5 microU/mL) that differs from thyrotoxicosis, wherein the TSH response is suppressed under 1 microU/mL. The cause of the blunted TSH is uncertain but is not due to hyperthyroidism. In contrast, close to 15% may have a TSH hyperresponse to TRH and/or elevated antithyroid antibodies. Thyroid hormone treatment may benefit the depression in some of these cases. In the sick thyroid state of nonthyroidal illness, a low T3 level is the initial manifestation. In more severe cases, the T4 also falls, the free T4 level in this situation is variable, both normal and low levels being reported from different laboratories. A diagnosis of hypothyroidism requiring treatment with thyroid hormone therapy is unlikely unless there is a concomitant lowfree T4 and elevated TSH in a patient who is not in the process of recovery. In acute psychiatric admissions, there is a high frequency of hyperthyroxinemia. The TSH in these cases is generally either normal or high, suggesting central activation of the hypothalamic-pituitary-thyroid axis. In most instances, the thyroid function tests normalize within 2 weeks, and treatment directed toward the thyroid gland is not indicated. Suppressed TSH levels, usually associated with a normal free T4, has also been described in such patients. Finally, various medications utilized in psychiatric practice have diverse effects on thyroid function and can cause diagnostic difficulty. These include lithium, phenytoin sodium, and carbamazepine, and their effects are reviewed.

摘要

高敏促甲状腺激素(TSH)免疫测定法的发展增进了人们对甲状腺激素调节的理解,但矛盾的是,却使非甲状腺疾病(NTI)住院患者甲状腺功能测试变异性变得异常复杂。在原发性甲状腺功能减退症中,TSH升高是最敏感的化学指标,不过早期病例在TSH仍处于正常范围时,可能显示TSH对促甲状腺激素释放激素(TRH)刺激反应过度。新型TSH测定法区分正常和低水平的能力,现在使得在血清甲状腺素(T4)和/或三碘甲状腺原氨酸(T3)升高的情况下,通过TSH被抑制来确诊甲状腺毒症成为可能。TRH刺激试验在甲状腺毒症诊断中实际上已过时,但在精神综合征的研究中仍备受关注。约25%的抑郁症患者TSH反应迟钝(升高幅度小于5微单位/毫升),这与甲状腺毒症不同,甲状腺毒症时TSH反应被抑制至1微单位/毫升以下。TSH反应迟钝的原因尚不确定,但并非由甲状腺功能亢进引起。相比之下,近15%的患者可能对TRH有TSH反应过度和/或抗甲状腺抗体升高。在其中一些病例中,甲状腺激素治疗可能对抑郁症有益。在非甲状腺疾病的病态甲状腺状态下,T3水平降低是最初表现。在更严重的病例中,T4也会下降,此时游离T4水平变化不定,不同实验室报告的既有正常水平也有低水平。除非在非恢复期患者中同时存在游离T4降低和TSH升高,否则不太可能诊断为需要用甲状腺激素治疗的甲状腺功能减退症。在急性精神科入院患者中,甲状腺素血症发生率很高。这些病例中的TSH通常正常或升高,提示下丘脑 - 垂体 - 甲状腺轴中枢激活。在大多数情况下,甲状腺功能测试在2周内恢复正常,无需针对甲状腺进行治疗。此类患者中也有TSH水平被抑制的情况,通常伴有游离T4正常。最后,精神科常用的各种药物对甲状腺功能有不同影响,可能导致诊断困难。这些药物包括锂盐、苯妥英钠和卡马西平,将对它们的影响进行综述。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验